|
|
| Line 1: |
Line 1: |
| ==Adult IV Concentrations== | | ==Adult IV Concentrations== |
| | | {| class="wikitable" |
| {| style="border: medium none" align="left" border="1"
| | | align="center" style="background:#f0f0f0;"|'''dication''' |
| | | align="center" style="background:#f0f0f0;"|'''Indications''' |
| | | align="center" style="background:#f0f0f0;"|'''Concentration''' |
| | | align="center" style="background:#f0f0f0;"|'''StartRange''' |
| | | align="center" style="background:#f0f0f0;"|'''Maximum''' |
| | | align="center" style="background:#f0f0f0;"|'''Comments''' |
| | |- |
| | | Amiodarone||SVT, UnstableVT, V-fib, Convert Afib to NSR||900mg/500mL D5Ws (1.8mg/ml)||150mg x10minà1mg/min x6hrsà0.5mg/min x18hr||2.2 gm/day||Watch for ↓BP,worsened/new arrythmias |
| | |- |
| | | Diltiazem||SVT, Afib/flutter||125mg/125mL D5W (1mg/ml)||Load 0.25mg/kgà5-15mg/hr||15mg/hr x 24hrs||Monitor BP, HR, EKG, SVR |
| | |- |
| | | Dobutamine||Refractory CHF, Cardiogenic Shock, use Dopamine first if BP low||500 mg/250mL D5W (2mg/ml)||Initial 1||20 mcg/kg/min||monitor BP, EKG, UOP |
| | |- |
| | | ||||||mcg/kg/min||||Tachydysrhythmias |
| | |- |
| | | ||||||à 2mcg/kg/min||||caution AMI, incr O2 req |
| | |- |
| | | Dopamine||HypoTN p volume resus, cardiog shock, bradycard||800 mg/250mL D5W||1-5 mcg/kg/min (renal 0.5-2)||20 mcg/kg/min||Monitor BP, EKG, UOP |
| | |- |
| | | D>B>B/A>A||||||||||tachydysrthm when d/c |
| | |- |
| | | Epinephrine||VF or pulseless VT, Asystole, PEA, decr SVR||8 mg/250mL D5W||1-10 mcg/min||20 mcg/min||Tachydysrhythmias |
| | |- |
| | | ||||||||||increase O2 demand |
| | |- |
| | | Esmolol||Reduce VF in post MI, convert SVT/Afib/flut, decr AMI ischem||2.5gm/250mL||Load 500 mcg/kg x1min à50 mcg/kg/min||300 mcg/kg/min||Careful: bradycardia, AV block, dec BP, reactive airway, no mix c Ca Ch Blk |
| | |- |
| | | ||||NS|||||| |
| |- | | |- |
| | style="width: 36px; background-color: rgb(217, 217, 217); height: 5px; border: 1pt solid" valign="top" width="43" | | | | Fentanyl||Sedation, pain||1mg/100mL NS||0.5-1mcg/kg/hr||5 mcg/kg/hr||Resp depression |
| '''<font face="Arial">Medication</font>'''
| |
| | |
| | style="width: 60px; background-color: rgb(217, 217, 217); height: 5px" valign="top" width="60" | | |
| '''<font face="Arial">Indications</font>'''
| |
| | |
| | style="width: 40px; background-color: rgb(217, 217, 217); height: 5px" valign="top" width="48" | <center>'''<font face="Arial">Concentration</font>'''</center>
| |
| | style="width: 40px; background-color: rgb(217, 217, 217); height: 5px" valign="top" width="48" | <center>'''<font face="Arial">Start</font><font face="Arial">Range</font>'''</center> | |
| | style="width: 36px; background-color: rgb(217, 217, 217); height: 5px" valign="top" width="36" | <center>'''<font face="Arial">Maximum</font>'''</center> | |
| | style="width: 60px; background-color: rgb(217, 217, 217); height: 5px" valign="top" width="72" | | |
| '''<font face="Arial">Comments</font>'''
| |
| | |
| |- | | |- |
| | style="width: 36px; height: 20px" valign="top" width="43" | | | | Furosemide||Diuresis||500mg/100mLD5||10mg/hr||100 mg/hr||Monitor UOP, Cr, lytes |
| <font face="Arial">Amiodarone</font>
| |
| | |
| | style="width: 60px; height: 20px" valign="top" width="60" | | |
| <font face="Arial">SVT, </font><font face="Arial">Unstable</font><font face="Arial">VT</font><font face="Arial">, V-fib, Convert Afib to NSR</font>
| |
| | |
| | style="width: 40px; height: 20px" valign="top" width="48" | <center><span lang="de"><font face="Arial">900mg/500mL D5Ws (1.8mg/ml)</font></span></center> | |
| | style="width: 40px; height: 20px" valign="top" width="48" | <center><span lang="de"><font face="Arial">150mg x10min</font></span><font face="Wingdings">à</font><font face="Arial">1mg/min x6hrs</font><font face="Wingdings">à</font><font face="Arial">0.5mg/min x18hr</font></center> | |
| | style="width: 36px; height: 20px" valign="top" width="36" | | |
| <font face="Arial">2.2 gm/day</font>
| |
| | |
| | style="width: 60px; height: 20px" valign="top" width="72" | | |
| <font face="Arial">Watch for ↓BP,</font><font face="Arial">worsened/new arrythmias</font>
| |
| | |
| |- | | |- |
| | style="width: 36px; height: 11px" valign="top" width="43" | | | | Insulin (reg)||BS control||100units/100mL NS||Load 0.1units/kgà0.1-0.7units/hr||10||Use Insulin protocol form |
| <font face="Arial">Diltiazem</font>
| |
| | |
| | style="width: 60px; height: 11px" valign="top" width="60" | | |
| <font face="Arial">SVT, Afib/flutter</font>
| |
| | |
| | style="width: 40px; height: 11px" valign="top" width="48" | <center><font face="Arial">125mg/125mL D5W (1mg/ml)</font></center> | |
| | style="width: 40px; height: 11px" valign="top" width="48" | | |
| <font face="Arial">Load 0.25mg/kg </font><span lang="de"><font face="Wingdings">à</font></span><font face="Arial">5-15mg/hr</font>
| |
| | |
| | style="width: 36px; height: 11px" valign="top" width="36" | <center><font face="Arial">15mg/hr x 24hrs</font></center> | |
| | style="width: 60px; height: 11px" valign="top" width="72" | | |
| <font face="Arial">Monitor BP, HR, EKG, SVR</font>
| |
| | |
| |- | | |- |
| | style="width: 36px; height: 11px" valign="top" width="43" | | | | ||||||||units/hr|| |
| <font face="Arial">Dobutamine</font>
| |
| | |
| | style="width: 60px; height: 11px" valign="top" width="60" | | |
| <font face="Arial">Refractory CHF, Cardiogenic Shock, use Dopamine first if BP low</font>
| |
| | |
| | style="width: 40px; height: 11px" valign="top" width="48" | <center><font face="Arial">500 mg/250mL D5W (2mg/ml)</font></center> | |
| | style="width: 40px; height: 11px" valign="top" width="48" | | |
| <span lang="de"><font face="Arial">Initial 1 </font></span>
| |
| | |
| <span lang="de"><font face="Arial">mcg/kg/min</font></span>
| |
| <center><font face="Wingdings">à</font><span lang="de"><font face="Arial"> 2mcg/kg/min</font></span></center>
| |
| | style="width: 36px; height: 11px" valign="top" width="36" | <center><font face="Arial">20 mcg/kg/min</font></center>
| |
| | style="width: 60px; height: 11px" valign="top" width="72" | | |
| <font face="Arial">monitor BP, EKG, UOP</font>
| |
| | |
| <font face="Arial">Tachydysrhythmias</font>
| |
| | |
| <font face="Arial">caution AMI, incr O2 req</font>
| |
| | |
| |- | | |- |
| | style="width: 36px; height: 14px" valign="top" width="43" | | | | Labetalol||HTN urg/emerg||200mg/300mL D5W||2mg/min||4mg/min||hypotension |
| <font face="Arial">Dopamine</font>
| |
| | |
| <font face="Arial">D>B>B/A>A</font>
| |
| | |
| | style="width: 60px; height: 14px" valign="top" width="60" |
| |
| <font face="Arial">HypoTN p volume resus, cardiog shock, bradycard</font>
| |
| | |
| | style="width: 40px; height: 14px" valign="top" width="48" | <center><font face="Arial">800 mg/250mL D5W</font></center> | |
| | style="width: 40px; height: 14px" valign="top" width="48" | <center><font face="Arial">1-5 mcg/kg/min (renal 0.5-2)</font></center> | |
| | style="width: 36px; height: 14px" valign="top" width="36" | <center><font face="Arial">20 mcg/kg/min</font></center> | |
| | style="width: 60px; height: 14px" valign="top" width="72" | | |
| <font face="Arial">Monitor BP, EKG, UOP</font>
| |
| | |
| <font face="Arial">tachydysrthm when d/c</font>
| |
| | |
| |- | | |- |
| | style="width: 36px; height: 11px" valign="top" width="43" | | | | Midazolam||Sedation intubated pt||100mg/100mL D5W||Load 10- 50 mcg/kgà20-100||||hypotension |
| <font face="Arial">Epinephrine</font>
| |
| | |
| | style="width: 60px; height: 11px" valign="top" width="60" |
| |
| <font face="Arial">VF or pulseless VT, Asystole, PEA, decr SVR</font>
| |
| | |
| | style="width: 40px; height: 11px" valign="top" width="48" | <center><font face="Arial">8 mg/250mL D5W</font></center> | |
| | style="width: 40px; height: 11px" valign="top" width="48" | <center><font face="Arial">1-10 mcg/min</font></center> | |
| | style="width: 36px; height: 11px" valign="top" width="36" | <center><font face="Arial">20 mcg/min</font></center> | |
| | style="width: 60px; height: 11px" valign="top" width="72" | | |
| <font face="Arial">Tachydysrhythmias</font>
| |
| | |
| <font face="Arial">increase O2 demand</font>
| |
| | |
| |- | | |- |
| | style="width: 36px; height: 20px" valign="top" width="43" | | | | (Versed)|||||||||| |
| <font face="Arial">Esmolol</font>
| |
| | |
| | style="width: 60px; height: 20px" valign="top" width="60" | | |
| <font face="Arial">Reduce VF in post MI, convert SVT/Afib/flut, decr AMI ischem</font>
| |
| | |
| | style="width: 40px; height: 20px" valign="top" width="48" | <center><font face="Arial">2.5gm/250mL</font></center><center><font face="Arial">NS</font></center> | |
| | style="width: 40px; height: 20px" valign="top" width="48" | <center><font face="Arial">Load 500 mcg/kg x1min </font><font face="Wingdings">à</font><font face="Arial">50 mcg/kg/min</font></center> | |
| | style="width: 36px; height: 20px" valign="top" width="36" | <center><font face="Arial">300 mcg/kg/min</font></center> | |
| | style="width: 60px; height: 20px" valign="top" width="72" | | |
| <font face="Arial">Careful: bradycardia, AV block, dec BP, reactive airway, no mix c Ca Ch Blk</font>
| |
| | |
| |- | | |- |
| | style="width: 36px; height: 8px" valign="top" width="43" | | | | Neo-syneph (phenyleph)||Hypotension, vascular failure in shock, SVT||80 mg/250mL D5W||Load 100 mcgà||200 mcg/min||Monitor BP, HR, SVR |
| <font face="Arial">Fentanyl</font>
| |
| | |
| | style="width: 60px; height: 8px" valign="top" width="60" | | |
| <font face="Arial">Sedation, pain</font>
| |
| | |
| | style="width: 40px; height: 8px" valign="top" width="48" | <center><font face="Arial">1mg/100mL NS</font></center> | |
| | style="width: 40px; height: 8px" valign="top" width="48" | <center><font face="Arial">0.5-1mcg/kg/hr</font></center> | |
| | style="width: 36px; height: 8px" valign="top" width="36" | | |
| <font face="Arial">5 mcg/kg/hr</font>
| |
| | |
| | style="width: 60px; height: 8px" valign="top" width="72" | | |
| <font face="Arial">Resp depression</font>
| |
| | |
| |- | | |- |
| | style="width: 36px; height: 8px" valign="top" width="43" | | | | ||||||40-60 mcg/min|||| |
| <font face="Arial">Furosemide</font>
| |
| | |
| | style="width: 60px; height: 8px" valign="top" width="60" | | |
| <font face="Arial">Diuresis</font>
| |
| | |
| | style="width: 40px; height: 8px" valign="top" width="48" | | |
| <font face="Arial">500mg/100mLD5</font>
| |
| | |
| | style="width: 40px; height: 8px" valign="top" width="48" | <center><font face="Arial">10mg/hr</font></center> | |
| | style="width: 36px; height: 8px" valign="top" width="36" | <center><font face="Arial">100 mg/hr</font></center> | |
| | style="width: 60px; height: 8px" valign="top" width="72" | | |
| <font face="Arial">Monitor UOP, Cr, lytes</font>
| |
| | |
| |- | | |- |
| | style="width: 36px; height: 8px" valign="top" width="43" | | | | NTG||AMI and Ischemia/Infarction||100 mg/250mL D5W||0.1 mcg/kg/min||5 mcg/kg/min||Hypotension, HA |
| <font face="Arial">Insulin (reg)</font>
| |
| | |
| | style="width: 60px; height: 8px" valign="top" width="60" | | |
| <font face="Arial">BS control</font>
| |
| | |
| | style="width: 40px; height: 8px" valign="top" width="48" | <center><font face="Arial">100units/100mL NS</font></center> | |
| | style="width: 40px; height: 8px" valign="top" width="48" | <center><font face="Arial">Load 0.1units/kg </font><font face="Wingdings">à</font><font face="Arial">0.1-0.7units/hr</font></center> | |
| | style="width: 36px; height: 8px" valign="top" width="36" | <center><font face="Arial">10</font></center><center><font face="Arial">units/hr</font></center> | |
| | style="width: 60px; height: 8px" valign="top" width="72" | | |
| <font face="Arial">Use Insulin protocol form</font>
| |
| | |
| |- | | |- |
| | style="width: 36px; height: 8px" valign="top" width="43" | | | | Nitroprussid||Hypertensive crisis||100 mg/250mL D5W||0.5 mcg/kg/min||10 mcg/kg/min||Watch BP, thiocynate tox, tinnitus, delirium, CP,vision |
| <font face="Arial">Labetalol</font>
| |
| | |
| | style="width: 60px; height: 8px" valign="top" width="60" |
| |
| <font face="Arial">HTN urg/emerg</font>
| |
| | |
| | style="width: 40px; height: 8px" valign="top" width="48" | <center><font face="Arial">200mg/300mL D5W</font></center> | |
| | style="width: 40px; height: 8px" valign="top" width="48" | <center><font face="Arial">2mg/min</font></center> | |
| | style="width: 36px; height: 8px" valign="top" width="36" | <center><font face="Arial">4mg/min</font></center> | |
| | style="width: 60px; height: 8px" valign="top" width="72" | | |
| <font face="Arial">hypotension</font>
| |
| | |
| |- | | |- |
| | style="width: 36px; height: 8px" valign="top" width="43" | | | | (Nipride)||Heart failure|||||||| |
| <font face="Arial">Midazolam</font>
| |
| | |
| <font face="Arial">(Versed)</font>
| |
| | |
| | style="width: 60px; height: 8px" valign="top" width="60" | | |
| <font face="Arial">Sedation intubated pt</font>
| |
| | |
| | style="width: 40px; height: 8px" valign="top" width="48" | <center><font face="Arial">100mg/100mL D5W</font></center> | |
| | style="width: 40px; height: 8px" valign="top" width="48" | <center><font face="Arial">Load 10- 50 mcg/kg</font><font face="Wingdings">à</font><font face="Arial">20-100</font></center> | |
| | style="width: 36px; height: 8px" valign="top" width="36" | <br/> | |
| | style="width: 60px; height: 8px" valign="top" width="72" | | |
| <font face="Arial">hypotension</font>
| |
| | |
| |- | | |- |
| | style="width: 36px; height: 8px" valign="top" width="43" | | | | Norepineph||Cardiogenic shock, Sig hypoTN w/ SBP <70||8 mg/250mL D5W||2 mcg/min||20||Monitor BP, EKG, UO caution in AMI |
| <font face="Arial">Neo-syneph (phenyleph)</font>
| |
| | |
| | style="width: 60px; height: 8px" valign="top" width="60" |
| |
| <font face="Arial">Hypotension, vascular failure in shock, SVT</font>
| |
| | |
| | style="width: 40px; height: 8px" valign="top" width="48" | <center><font face="Arial">80 mg/250mL D5W</font></center> | |
| | style="width: 40px; height: 8px" valign="top" width="48" | | |
| <font face="Arial">Load 100 mcg</font><font face="Wingdings">à</font>
| |
| <center><font face="Arial">40-60 mcg/min</font></center>
| |
| | style="width: 36px; height: 8px" valign="top" width="36" | <center><font face="Arial">200 mcg/min</font></center> | |
| | style="width: 60px; height: 8px" valign="top" width="72" | | |
| <font face="Arial">Monitor BP, HR, SVR</font>
| |
| | |
| |- | | |- |
| | style="width: 36px; height: 8px" valign="top" width="43" | | | | (levophed)||||||||mcg/min|| |
| <font face="Arial">NTG</font>
| |
| | |
| | style="width: 60px; height: 8px" valign="top" width="60" | | |
| <font face="Arial">AMI and Ischemia/Infarction</font>
| |
| | |
| | style="width: 40px; height: 8px" valign="top" width="48" | <center><font face="Arial">100 mg/250mL D5W</font></center> | |
| | style="width: 40px; height: 8px" valign="top" width="48" | <center><font face="Arial">0.1 mcg/kg/min</font></center> | |
| | style="width: 36px; height: 8px" valign="top" width="36" | <center><font face="Arial">5 mcg/kg/min</font></center>
| |
| | style="width: 60px; height: 8px" valign="top" width="72" | | |
| <font face="Arial">Hypotension, HA</font>
| |
| | |
| |- | | |- |
| | style="width: 36px; height: 8px" valign="top" width="43" | | | | Octreotide||GI Bleed||1250mcg/250mL D5W||50 mcg bolus||50mcg/hr||Dysglycemia, bradycardia, hypothyroidism |
| <font face="Arial">Nitroprussid</font>
| |
| | |
| <font face="Arial">(Nipride)</font>
| |
| | |
| | style="width: 60px; height: 8px" valign="top" width="60" | | |
| <font face="Arial">Hypertensive crisis</font>
| |
| | |
| <font face="Arial">Heart failure</font>
| |
| | |
| | style="width: 40px; height: 8px" valign="top" width="48" | <center><font face="Arial">100 mg/250mL D5W</font></center> | |
| | style="width: 40px; height: 8px" valign="top" width="48" | <center><font face="Arial">0.5 mcg/kg/min</font></center> | |
| | style="width: 36px; height: 8px" valign="top" width="36" | <center><font face="Arial">10 mcg/kg/min</font></center> | |
| | style="width: 60px; height: 8px" valign="top" width="72" | | |
| <font face="Arial">Watch BP, thiocynate tox, tinnitus, delirium, CP,vision</font>
| |
| | |
| |- | | |- |
| | style="width: 36px; height: 14px" valign="top" width="43" | | | | ||||||à25 mcg/hr|||| |
| <font face="Arial">Norepineph</font>
| |
| | |
| <font face="Arial">(levophed)</font>
| |
| | |
| | style="width: 60px; height: 14px" valign="top" width="60" | | |
| <font face="Arial">Cardiogenic shock, Sig hypoTN w/ SBP <70</font>
| |
| | |
| | style="width: 40px; height: 14px" valign="top" width="48" | <center><font face="Arial">8 mg/250mL D5W</font></center> | |
| | style="width: 40px; height: 14px" valign="top" width="48" | <center><font face="Arial">2 mcg/min</font></center>
| |
| | style="width: 36px; height: 14px" valign="top" width="36" | <center><font face="Arial">20</font></center><center><font face="Arial">mcg/min</font></center> | |
| | style="width: 60px; height: 14px" valign="top" width="72" | | |
| <font face="Arial">Monitor BP, EKG, UO caution in AMI</font>
| |
| | |
| |- | | |- |
| | style="width: 36px; height: 6px" valign="top" width="43" | | | | Protonix||GI Bleed||||80mg bolusà8mg/hr||8mg/hr|| |
| <font face="Arial">Octreotide</font>
| |
| | |
| | style="width: 60px; height: 6px" valign="top" width="60" |
| |
| <font face="Arial">GI Bleed</font>
| |
| | |
| | style="width: 40px; height: 6px" valign="top" width="48" | <center><font face="Arial">1250mcg/250mL D5W</font></center> | |
| | style="width: 40px; height: 6px" valign="top" width="48" | <center><font face="Arial">50 mcg bolus</font></center><center><font face="Wingdings">à</font><font face="Arial">25 mcg/hr</font></center> | |
| | style="width: 36px; height: 6px" valign="top" width="36" | <center><font face="Arial">50mcg/hr</font></center> | |
| | style="width: 60px; height: 6px" valign="top" width="72" | | |
| <font face="Arial">Dysglycemia, bradycardia, hypothyroidism</font>
| |
| | |
| |- | | |- |
| | style="width: 36px; height: 6px" valign="top" width="43" | | | | Vasopressn||vasodilatory shock, pulseless VF/VT, DI, GIB||100 units||0.04 units/min||1.0 unit/min||Inc SVR ++periph vasoconstr, bad in AMI; do not titrate for vasodilatory shock |
| <font face="Arial">Protonix</font>
| |
| | |
| | style="width: 60px; height: 6px" valign="top" width="60" | | |
| <font face="Arial">GI Bleed</font>
| |
| | |
| | style="width: 40px; height: 6px" valign="top" width="48" | <br/> | |
| | style="width: 40px; height: 6px" valign="top" width="48" | <center><font face="Arial">80mg bolus </font><font face="Wingdings">à</font><font face="Arial">8mg/hr</font></center> | |
| | style="width: 36px; height: 6px" valign="top" width="36" | <center><font face="Arial">8mg/hr</font></center>
| |
| | style="width: 60px; height: 6px" valign="top" width="72" | <br/> | |
| |- | | |- |
| | style="width: 36px; height: 6px" valign="top" width="43" | | | | (Pitressin)||||/250mL D5W|||||| |
| <font face="Arial">Vasopressn</font>
| |
| | |
| <font face="Arial">(Pitressin)</font>
| |
| | |
| | style="width: 60px; height: 6px" valign="top" width="60" | | |
| <font face="Arial">vasodilatory shock, pulseless VF/VT, DI, GIB</font>
| |
| | |
| | style="width: 40px; height: 6px" valign="top" width="48" | <center><font face="Arial">100 units</font></center><center><font face="Arial">/250mL D5W</font></center> | |
| | style="width: 40px; height: 6px" valign="top" width="48" | <center><font face="Arial">0.04 units/min</font></center> | |
| | style="width: 36px; height: 6px" valign="top" width="36" | <center><font face="Arial">1.0 unit/min</font></center> | |
| | style="width: 60px; height: 6px" valign="top" width="72" | | |
| <font face="Arial">Inc SVR ++periph vasoconstr, bad in AMI; do not titrate for vasodilatory shock</font>
| |
| | |
| |} | | |} |
|
| |
|
| <br/>[[Category:Drugs]]
| | [[Category:Drugs]] |
